임상시험

Phase 1/2a Study of ANPD001 in Parkinson Disease

NCT: NCT06344026 · ENROLLING_BY_INVITATION

NCT IDNCT06344026

상태ENROLLING_BY_INVITATION

시작일2024-01-23

완료2030-04-30

SponsorAspen Neuroscience (INDUSTRY)

First posted2024-04-03

Last updated2026-05-14

간략 요약

This clinical trial is designed to test the safety and tolerability of injecting ANPD001 cells that will mature into dopamine-producing cells into the brain of participants with Parkinson Disease. All participants will have ANPD001 cells manufactured from their own previously collected cells.

공식 출처

ClinicalTrials.gov에서 보기 →

데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.